Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ImmuCell Corporation - Common Stock (NQ:ICCC)

10.08 -0.01 (-0.10%)
Streaming Delayed Price Updated: 2:45 PM EDT, Aug 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,779
Open 10.09
Bid (Size) 10.05 (200)
Ask (Size) 10.42 (300)
Prev. Close 10.09
Today's Range 10.05 - 10.49
52wk Range 4.520 - 12.10
Shares Outstanding 7,741,864
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
ImmuCell (ICCC) Q2 2026 Earnings Call Transcript ↗
Product sales hit $7.2 million as market share climbed to 19% amid capacity expansion plans. 
Via The Motley Fool
Topics Earnings
News headline image
ImmuCell Reports Q2 2026 Results: Full Earnings Call Transcript ↗
ImmuCell (NASDAQ:ICCC) released second-quarter financial results and hosted an earnings call on Friday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive... 
Via Benzinga
Topics Earnings

Performance

YTD
+70.3%
+70.3%
1 Month
-10.0%
-10.0%
3 Month
+0.7%
+0.7%
6 Month
+51.1%
+51.1%
1 Year
+66.8%
+66.8%

More News

Read More
News headline image
ImmuCell Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
ImmuCell Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
The Christmas Party Is Still Ongoing In These Stocks: Nvidia, Sidus Space, Coupang, Vanda Pharmaceuticals, ImmuCell ↗
Via Stocktwits
News headline image
Earnings Scheduled For November 13, 2025 ↗
Via Benzinga
News headline image
Earnings Scheduled For August 14, 2025 ↗
Via Benzinga
News headline image
ImmuCell (ICCC) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
Regulatory Roadblock: ImmuCell Pivots to Core Growth After FDA Rejects Mastitis Treatment
Via MarketMinute
News headline image
ImmuCell Q2 Profit Jumps as Margins Rise ↗
Via The Motley Fool
News headline image
Earnings Scheduled For February 25, 2025 ↗
Via Benzinga
News headline image
Earnings Scheduled For November 13, 2024 ↗
Via Benzinga
News headline image
ICCC Stock Earnings: ImmuCell Beats Revenue for Q2 2024 ↗
Via InvestorPlace
News headline image
ICCC Stock Earnings: ImmuCell Reported Results for Q1 2024 ↗
Via InvestorPlace
News headline image
ImmuCell ICCC Q2 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
ImmuCell Posts 18% Gain in Q2 ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
News headline image
Earnings Scheduled For February 27, 2024 ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Via Benzinga
News headline image
Top Stock Reports For Apple, Eli Lilly & Shopify ↗
Via Talk Markets
Topics Stocks / Equities
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
PriceSmart, Kura Sushi And 3 Stocks To Watch Heading Into Wednesday ↗
Via Benzinga
News headline image
Earnings Scheduled For May 14, 2025 ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga

Frequently Asked Questions

Is ImmuCell Corporation - Common Stock publicly traded?
Yes, ImmuCell Corporation - Common Stock is publicly traded.
What exchange does ImmuCell Corporation - Common Stock trade on?
ImmuCell Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ImmuCell Corporation - Common Stock?
The ticker symbol for ImmuCell Corporation - Common Stock is ICCC on the Nasdaq Stock Market
What is the current price of ImmuCell Corporation - Common Stock?
The current price of ImmuCell Corporation - Common Stock is 10.08
When was ImmuCell Corporation - Common Stock last traded?
The last trade of ImmuCell Corporation - Common Stock was at 08/21/26 02:45 PM ET
What is the market capitalization of ImmuCell Corporation - Common Stock?
The market capitalization of ImmuCell Corporation - Common Stock is 78.04M
How many shares of ImmuCell Corporation - Common Stock are outstanding?
ImmuCell Corporation - Common Stock has 78M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.